Author page: Femtech Insider

What’s New in Femtech This Week? (April 29, 2021)

Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. Highlights Period Apparel Company Ruby Love secures a new round of investment led by SteelSky Ventures. Unilever Ventures-backed Womaness launches a collection of new menopause products. Rhia Ventures appoints…

Finance Exec Meredith Whitney Joins Kindbody as the Company’s New CFO

Kindbody today announced Meredith Whitney as its Chief Financial Officer and newest addition to its female-led executive team. Whitney joins Kindbody as a seasoned leader with a long and illustrious career in finance, having shattered the glass ceiling during her time on Wall Street. Whitney has been one of the most visible female analysts on Wall Street, earning recognition from Fortune Magazine as one…

Frost & Sullivan Awards OCON Healthcare with the 2021 Global Enabling Technology Leadership Award

Based on its recent analysis of the global intrauterine device (IUD) market, Frost & Sullivan recognizes OCON Healthcare (OCON) with the 2021 Global Enabling Technology Leadership Award for creating the world’s first and only 3D spherical copper IUD, the Intra Uterine Ball (IUB) Ballerine. The IUD is made from nitinol, a super-elastic alloy that can retain shape and is an ideal transporter of drugs to the…

Contraception: Evofem Announces the Presentation of Two New Phexxi Data Sets at the 2021 American College of Obstetricians and Gynecologists Annual Meeting

Evofem Biosciences has announced that two new data sets from its Phase 3 AMPOWER trial evaluating Phexxi (lactic acid, citric acid, potassium bitartrate) will be presented at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting (ACSM). The meeting will be conducted virtually from April 30 – May 2, 2021. “These new data sets provide clinical insights into how women used Phexxi…

Meet Mirvie, a Femtech Startup Creating a Blood Test for Early Detection of Pregnancy Complications

Earlier today Mirvie announced it is making rapid progress toward developing a simple, personalized blood test with the potential for early detection of pregnancy complications, such as preterm birth, preeclampsia and gestational diabetes, which affect 1 in 5 women. Currently, there is no reliable way to identify if a mother is at risk for these significant pregnancy complications. Pregnancy complications, such as…

All Raise Annual Report: “2020 was not a good year for women and non-binary individuals in tech and venture.”

All Raise was initially born our of a grassroots movement in 2017 to arm women with access guidance and support to advance their professional growth. Today the organization is on a mission to accelerate the success of female founders and funders to build a more prosperous, equitable future. Yesterday All Raise published its latest Annual Report and truly 2020 wasn’t a great…

Rhia Ventures Appoints Erika Seth Davies as New CEO

Rhia Ventures is on a mission is to create a vibrant U.S. market for sexual, reproductive, and maternal health that produces equitable outcomes for all. The firm makes direct investments in early- and growth-stage companies, provides technical assistance and resources to portfolio companies, and organizes corporate engagement programs to change social norms, practices, and people that influence the market. Yesterday the firm announced…

U.S. Reality TV Personality Cynthia Bailey-Hill Supports Reponsum, a New Fibroid App & Online Patient Community

Today, Real Housewives of Atlanta star Cynthia Bailey-Hill announced her support for Responsum for Fibroids, an online empowerment, knowledge, and support platform for women with uterine fibroids, a condition that affects 70-80% of all women by the age of 50. Provided in partnership with CARE About Fibroids and The White Dress Project—two of the nation’s leading fibroids support organizations—and underwritten with independent support from AbbVie, a global…